Green Alpha Advisors, LLC Caribou Biosciences, Inc. Transaction History
Green Alpha Advisors, LLC
- $112 Million
- Q4 2024
A detailed history of Green Alpha Advisors, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Green Alpha Advisors, LLC holds 181,054 shares of CRBU stock, worth $199,159. This represents 0.26% of its overall portfolio holdings.
Number of Shares
181,054
Previous 103,214
75.42%
Holding current value
$199,159
Previous $201,000
42.79%
% of portfolio
0.26%
Previous 0.16%
Shares
14 transactions
Others Institutions Holding CRBU
# of Institutions
138Shares Held
54.4MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$7.64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$5.02 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$4.26 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$3.02 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$2.75 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $66.9M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...